This inventor holds 1 USPTO granted patent. Top assignee: Pliva-Lachema A.s.. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: The Innovations of Ronald Gust
Introduction
Ronald Gust is a notable inventor based in Schierling, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antitumor compositions. His work has the potential to impact cancer treatment positively.
Latest Patents
One of Ronald Gust's key inventions is a pharmaceutical composition with antitumor activity based on carboplatin. This invention involves an aqueous solution of carboplatin with a content ranging from 1 to 20 mg·ml. The composition is designed to contain less than 0.1% by weight of 1,1-cyclobutanedicarboxylic acid (CBDCA) and/or its salt, based on the weight of the carboplatin present. This innovative approach aims to enhance the efficacy of carboplatin in cancer therapy.
Career Highlights
Ronald Gust has been associated with Pliva-Lachema A.S., where he has contributed to various pharmaceutical advancements. His expertise in the field has led to the development of effective treatments that address critical health challenges.
Collaborations
Throughout his career, Ronald has collaborated with esteemed colleagues, including Vladimír Kysilka and Libuse Zatloukalová. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
In summary, Ronald Gust's contributions to pharmaceutical innovations, particularly in antitumor compositions, highlight his role as a significant inventor in the field. His work continues to pave the way for advancements in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile